Imi Faghmous

Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study

Bijal Shah, Armin Ghobadi, Olalekan O. Oluwole et al. · Journal of Hematology & Oncology · 2022 · 76 citations · Full text

Medicine, Hematology, Oncology +15

Approaches to Selecting “Time Zero” in External Control Arms with Multiple Potential Entry Points: A Simulation Study of 8 Approaches

Anthony J. Hatswell, Kevin Deighton, Julia Thornton Snider et al. · Medical Decision Making · 2022 · 14 citations · Full text

Pharmacy, Biostatistics, Pharmacoeconomics +9

Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States

Bijal Shah, Nathaniel Smith, Chaoling Feng et al. · Advances in Therapy · 2022 · 13 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17

Estimating the risk of thrombotic events in people with congenital hemophilia A using US claims data

Imi Faghmous, Francis Nissen, Peter Kuebler et al. · Journal of Comparative Effectiveness Research · 2021 · 11 citations · Full text

Medicine, Hematology, Clinical Epidemiology +15